Salesforce and CVS Health announced a stratergic relationship to use both company's COVID-19 return to work and campus solutions

Cision PR Newswire | August 11, 2020

Salesforce (NYSE: CRM), the global leader in CRM, today announced a strategic relationship with CVS Health (NYSE: CVS) that will allow customers to use each company's COVID-19 return to work and campus solutions together, as they transition employees and students back to worksite and campus locations. The offering will enable customers to use Salesforce Work.com workplace management capabilities, including wellness monitoring and manual contact tracing solutions, informed by CVS Health's Return Ready, a flexible COVID-19 testing solution, to support comprehensive reopening strategies for customers and their stakeholders. Both companies launched separate solutions to help organizations strengthen their response to COVID-19. Salesforce created Work.com, a suite of applications and advisory resources, to help businesses reopen their workplaces while prioritizing the health of their stakeholders. CVS Health launched Return Ready, providing organizations with the flexibility of choosing from multiple COVID-19 testing options—from testing with licensed professionals onsite at the workplace to testing at one of the more than 1,800 CVS Pharmacy COVID-19 drive-thru testing locations.

Spotlight

Watch this video and find out how Google Cloud can help healthcare organizations accelerate innovation by enhancing care through new digital experiences, using insights to improve healthcare delivery and outcomes, and advancing research, drug discovery, and distribution at scale.


Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Spotlight

Watch this video and find out how Google Cloud can help healthcare organizations accelerate innovation by enhancing care through new digital experiences, using insights to improve healthcare delivery and outcomes, and advancing research, drug discovery, and distribution at scale.

Resources